Trichobrachin-IIA
| Internal ID | 1f67a9f1-4b78-4cc2-a000-72d92f39f256 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[2-[(2-acetamido-2-methylpropanoyl)amino]propanoylamino]-2-methylpropanoyl]amino]propanoylamino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C64H110N16O18/c1-31(2)29-38(47(87)77-64(22,23)57(98)80-28-24-25-39(80)48(88)71-43(33(5)6)50(90)91)69-41(83)30-66-51(92)58(10,11)78-49(89)42(32(3)4)72-55(96)61(16,17)76-46(86)37(26-27-40(65)82)70-54(95)62(18,19)79-56(97)63(20,21)75-45(85)35(8)68-53(94)60(14,15)74-44(84)34(7)67-52(93)59(12,13)73-36(9)81/h31-35,37-39,42-43H,24-30H2,1-23H3,(H2,65,82)(H,66,92)(H,67,93)(H,68,94)(H,69,83)(H,70,95)(H,71,88)(H,72,96)(H,73,81)(H,74,84)(H,75,85)(H,76,86)(H,77,87)(H,78,89)(H,79,97)(H,90,91) |
| InChI Key | XRDRZVACMTUBSJ-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C64H110N16O18 |
| Molecular Weight | 1391.70 g/mol |
| Exact Mass | 1390.81840072 g/mol |
| Topological Polar Surface Area (TPSA) | 508.00 Ų |
| XlogP | -0.70 |
| Atomic LogP (AlogP) | -2.97 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 36 |
| RefChem:191057 |
| 2-((1-(2-((2-((2-((2-((2-((2-((2-((2-((2-(2-((2-(2-((2-acetamido-2-methylpropanoyl)amino)propanoylamino)-2-methylpropanoyl)amino)propanoylamino)-2-methylpropanoyl)amino)-2-methylpropanoyl)amino)-5-amino-5-oxopentanoyl)amino)-2-methylpropanoyl)amino)-3-methylbutanoyl)amino)-2-methylpropanoyl)amino)acetyl)amino)-4-methylpentanoyl)amino)-2-methylpropanoyl)pyrrolidine-2-carbonyl)amino)-3-methylbutanoic acid |
| 2-((hydroxy(1-(2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxyethylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-2-methylpropylidene)amino)-2-methylpropylidene)amino)-4-(C-hydroxycarbonimidoyl)butylidene)amino)-2-methylpropylidene)amino)-3-methylbutylidene)amino)-2-methylpropylidene)amino)ethylidene)amino)-4-methylpentylidene)amino)-2-methylpropanoyl)pyrrolidin-2-yl)methylidene)amino)-3-methylbutanoate |
| 2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[2-[(2-acetamido-2-methylpropanoyl)amino]propanoylamino]-2-methylpropanoyl]amino]propanoylamino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid |
| 2-{[hydroxy(1-{2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-2-methylpropylidene}amino)propylidene]amino}-2-methylpropylidene)amino]propylidene}amino)-2-methylpropylidene]amino}-2-methylpropylidene)amino]-4-(C-hydroxycarbonimidoyl)butylidene}amino)-2-methylpropylidene]amino}-3-methylbutylidene)amino]-2-methylpropylidene}amino)ethylidene]amino}-4-methylpentylidene)amino]-2-methylpropanoyl}pyrrolidin-2-yl)methylidene]amino}-3-methylbutanoate |
| CHEBI:208306 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5550 | 55.50% |
| Caco-2 | - | 0.8573 | 85.73% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.5571 | 55.71% |
| Subcellular localzation | Lysosomes | 0.6003 | 60.03% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8623 | 86.23% |
| OATP1B3 inhibitior | + | 0.9414 | 94.14% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9358 | 93.58% |
| P-glycoprotein inhibitior | + | 0.7429 | 74.29% |
| P-glycoprotein substrate | + | 0.8459 | 84.59% |
| CYP3A4 substrate | + | 0.7168 | 71.68% |
| CYP2C9 substrate | + | 0.6058 | 60.58% |
| CYP2D6 substrate | - | 0.8683 | 86.83% |
| CYP3A4 inhibition | - | 0.8574 | 85.74% |
| CYP2C9 inhibition | - | 0.9062 | 90.62% |
| CYP2C19 inhibition | - | 0.7535 | 75.35% |
| CYP2D6 inhibition | - | 0.9292 | 92.92% |
| CYP1A2 inhibition | - | 0.9174 | 91.74% |
| CYP2C8 inhibition | + | 0.5408 | 54.08% |
| CYP inhibitory promiscuity | - | 0.9786 | 97.86% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.8600 | 86.00% |
| Carcinogenicity (trinary) | Non-required | 0.6100 | 61.00% |
| Eye corrosion | - | 0.9843 | 98.43% |
| Eye irritation | - | 0.8961 | 89.61% |
| Skin irritation | - | 0.7893 | 78.93% |
| Skin corrosion | - | 0.9071 | 90.71% |
| Ames mutagenesis | - | 0.6978 | 69.78% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6922 | 69.22% |
| Micronuclear | + | 0.5900 | 59.00% |
| Hepatotoxicity | + | 0.6823 | 68.23% |
| skin sensitisation | - | 0.8918 | 89.18% |
| Respiratory toxicity | + | 0.7222 | 72.22% |
| Reproductive toxicity | + | 0.8222 | 82.22% |
| Mitochondrial toxicity | + | 0.6500 | 65.00% |
| Nephrotoxicity | - | 0.8035 | 80.35% |
| Acute Oral Toxicity (c) | III | 0.6499 | 64.99% |
| Estrogen receptor binding | + | 0.5556 | 55.56% |
| Androgen receptor binding | + | 0.7259 | 72.59% |
| Thyroid receptor binding | + | 0.6631 | 66.31% |
| Glucocorticoid receptor binding | + | 0.7475 | 74.75% |
| Aromatase binding | + | 0.7392 | 73.92% |
| PPAR gamma | + | 0.7844 | 78.44% |
| Honey bee toxicity | - | 0.7905 | 79.05% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5076 | 50.76% |
| Fish aquatic toxicity | - | 0.4079 | 40.79% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL220 | P22303 | Acetylcholinesterase | 99.83% | 94.45% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.78% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.52% | 96.61% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 98.17% | 95.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.01% | 98.94% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 97.79% | 98.24% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.78% | 96.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.62% | 93.56% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.52% | 98.33% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 96.35% | 95.00% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 95.42% | 92.38% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.30% | 96.47% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.96% | 96.03% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.44% | 91.19% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 93.95% | 89.63% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.55% | 91.11% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 93.10% | 100.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 92.83% | 99.35% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 92.66% | 83.14% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 92.61% | 100.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.23% | 100.00% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 92.19% | 98.10% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 92.06% | 99.77% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 91.86% | 87.16% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.81% | 97.09% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.76% | 97.50% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 91.70% | 94.66% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 91.56% | 81.29% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 91.07% | 93.00% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 91.03% | 96.28% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 90.71% | 97.14% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 90.61% | 92.50% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 90.40% | 96.38% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 90.30% | 94.00% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 90.28% | 93.33% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 89.53% | 83.10% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 89.29% | 98.77% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 89.20% | 90.17% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.11% | 96.00% |
| CHEMBL4801 | P29466 | Caspase-1 | 88.93% | 96.85% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 88.88% | 96.67% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 88.72% | 98.89% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 88.18% | 95.71% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 87.88% | 89.50% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 87.38% | 95.38% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 86.94% | 90.71% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 86.69% | 97.29% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 86.41% | 99.17% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 86.08% | 90.24% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 85.92% | 93.04% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 85.55% | 97.43% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 84.87% | 97.21% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 84.57% | 97.23% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 84.47% | 97.25% |
| CHEMBL5028 | O14672 | ADAM10 | 84.42% | 97.50% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 84.05% | 97.50% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 83.82% | 94.33% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 83.53% | 99.17% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.14% | 100.00% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 82.52% | 98.33% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 82.41% | 92.80% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 82.41% | 82.05% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 82.31% | 88.42% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 82.02% | 82.69% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.93% | 95.89% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 81.90% | 96.31% |
| CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK | 81.80% | 88.89% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 81.72% | 95.36% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 81.14% | 94.45% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 81.04% | 95.89% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 80.80% | 96.67% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 80.40% | 97.64% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 80.36% | 96.67% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139588147 |
| LOTUS | LTS0266550 |
| wikiData | Q104201267 |